These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17156400)

  • 1. Gene expression profiles of erythroid precursors characterise several mechanisms of the action of hydroxycarbamide in sickle cell anaemia.
    Costa FC; da Cunha AF; Fattori A; de Sousa Peres T; Costa GG; Machado TF; de Albuquerque DM; Gambero S; Lanaro C; Saad ST; Costa FF
    Br J Haematol; 2007 Jan; 136(2):333-42. PubMed ID: 17156400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia.
    Flanagan JM; Steward S; Howard TA; Mortier NA; Kimble AC; Aygun B; Hankins JS; Neale GA; Ware RE
    Br J Haematol; 2012 Apr; 157(2):240-8. PubMed ID: 22360576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxycarbamide stimulates the production of proinflammatory cytokines by endothelial cells: relevance to sickle cell disease.
    Laurance S; Pellay FX; Dossou-Yovo OP; Verger E; Krishnamoorthy R; Lapoumeroulie C; Benecke A; Elion J
    Pharmacogenet Genomics; 2010 Apr; 20(4):257-68. PubMed ID: 20216336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxycarbamide reduces eosinophil adhesion and degranulation in sickle cell anaemia patients.
    Pallis FR; Conran N; Fertrin KY; Olalla Saad ST; Costa FF; Franco-Penteado CF
    Br J Haematol; 2014 Jan; 164(2):286-95. PubMed ID: 24383847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating sickle cell anaemia with hydroxycarbamide.
    Pollack S
    Br J Haematol; 2014 Jan; 164(2):296-7. PubMed ID: 24116862
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapy with hydroxyurea is associated with reduced adhesion molecule gene and protein expression in sickle red cells with a concomitant reduction in adhesive properties.
    Gambero S; Canalli AA; Traina F; Albuquerque DM; Saad ST; Costa FF; Conran N
    Eur J Haematol; 2007 Feb; 78(2):144-51. PubMed ID: 17313560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression of HIF-1α and VEGF in response to hypoxia in sickle cell anaemia: Influence of hydroxycarbamide.
    Pedrosa AM; Lemes RPG
    Br J Haematol; 2020 Jul; 190(1):e39-e42. PubMed ID: 32352161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxycarbamide for sickle-cell anaemia in infancy.
    Weatherall DJ
    Lancet; 2011 May; 377(9778):1628-30. PubMed ID: 21571132
    [No Abstract]   [Full Text] [Related]  

  • 9. Epigenetic and molecular profiles of erythroid cells after hydroxyurea treatment in sickle cell anemia.
    Walker AL; Steward S; Howard TA; Mortier N; Smeltzer M; Wang YD; Ware RE
    Blood; 2011 Nov; 118(20):5664-70. PubMed ID: 21921042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal haemoglobin response to hydroxycarbamide treatment and sar1a promoter polymorphisms in sickle cell anaemia.
    Kumkhaek C; Taylor JG; Zhu J; Hoppe C; Kato GJ; Rodgers GP
    Br J Haematol; 2008 Apr; 141(2):254-9. PubMed ID: 18318767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of differentially expressed genes induced by hydroxyurea in reticulocytes from sickle cell anaemia patients.
    Moreira LS; de Andrade TG; Albuquerque DM; Cunha AF; Fattori A; Saad ST; Costa FF
    Clin Exp Pharmacol Physiol; 2008 May; 35(5-6):651-5. PubMed ID: 18215186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood plasma metabolomics of children and adolescents with sickle cell anaemia treated with hydroxycarbamide: a new tool for uncovering biochemical alterations.
    Ribeiro PR; Teixeira RDS; Souza AR; Pereira TCS; Boffo EF; Carosio MGA; Ferreira AG; Oliveira RV; Rodrigues LEA; Silva JJ; de Souza AJ; Ladeia AMT
    Br J Haematol; 2021 Mar; 192(5):922-931. PubMed ID: 33476407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxycarbamide modulates components involved in the regulation of adenosine levels in blood cells from sickle-cell anemia patients.
    Silva-Pinto AC; Dias-Carlos C; Saldanha-Araujo F; Ferreira FI; Palma PV; Araujo AG; Queiroz RH; Elion J; Covas DT; Zago MA; Panepucci RA
    Ann Hematol; 2014 Sep; 93(9):1457-65. PubMed ID: 24696091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxycarbamide use in young children with sickle-cell anaemia.
    Takahashi Y; Mori J; Tsubokura M; Matsumura T; Kami M
    Lancet; 2011 Nov; 378(9805):1777. PubMed ID: 22098851
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydroxycarbamide use in young children with sickle-cell anaemia.
    Obaro SK; Inusa B; Telfer P
    Lancet; 2011 Nov; 378(9805):1777. PubMed ID: 22098850
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of hydroxyurea in a population of Brazilian patients with sickle cell anemia.
    Vicari P; Barretto de Mello A; Figueiredo MS
    Am J Hematol; 2005 Mar; 78(3):243-4. PubMed ID: 15726590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of hydroxcarbamide therapy on survival of children with sickle cell disease.
    Lobo CL; Pinto JF; Nascimento EM; Moura PG; Cardoso GP; Hankins JS
    Br J Haematol; 2013 Jun; 161(6):852-60. PubMed ID: 23590693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyurea downregulates endothelin-1 gene expression and upregulates ICAM-1 gene expression in cultured human endothelial cells.
    Brun M; Bourdoulous S; Couraud PO; Elion J; Krishnamoorthy R; Lapoumeroulie C
    Pharmacogenomics J; 2003; 3(4):215-26. PubMed ID: 12931135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of hydroxyurea-induced mutational effects supports higher utilisation for the treatment of sickle cell anaemia.
    Ware RE; Dertinger SD
    Br J Haematol; 2021 Jul; 194(2):252-266. PubMed ID: 33570176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy.
    Lanaro C; Franco-Penteado CF; Albuqueque DM; Saad ST; Conran N; Costa FF
    J Leukoc Biol; 2009 Feb; 85(2):235-42. PubMed ID: 19004988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.